Department of Medicine.
James P. Wilmot Cancer Institute, and.
JCI Insight. 2019 Apr 18;5(10):124213. doi: 10.1172/jci.insight.124213.
The bone marrow microenvironment (BMME) contributes to the regulation of hematopoietic stem cell (HSC) function, though its role in age-associated lineage skewing is poorly understood. Here we show that dysfunction of aged marrow macrophages (Mφs) directs HSC platelet-bias. Mφs from the marrow of aged mice and humans exhibited an activated phenotype, with increased expression of inflammatory signals. Aged marrow Mφs also displayed decreased phagocytic function. Senescent neutrophils, typically cleared by marrow Mφs, were markedly increased in aged mice, consistent with functional defects in Mφ phagocytosis and efferocytosis. In aged mice, Interleukin 1B (IL1B) was elevated in the bone marrow and caspase 1 activity, which can process pro-IL1B, was increased in marrow Mφs and neutrophils. Mechanistically, IL1B signaling was necessary and sufficient to induce a platelet bias in HSCs. In young mice, depletion of phagocytic cell populations or loss of the efferocytic receptor Axl expanded platelet-biased HSCs. Our data support a model wherein increased inflammatory signals and decreased phagocytic function of aged marrow Mφs induce the acquisition of platelet bias in aged HSCs. This work highlights the instructive role of Mφs and IL1B in the age-associated lineage-skewing of HSCs, and reveals the therapeutic potential of their manipulation as antigeronic targets.
骨髓微环境(BMME)有助于调节造血干细胞(HSC)的功能,但它在与年龄相关的谱系倾斜中的作用知之甚少。在这里,我们表明,衰老骨髓巨噬细胞(Mφs)的功能障碍导致 HSC 血小板偏向。来自老年小鼠和人类骨髓的 Mφs 表现出激活表型,炎症信号表达增加。衰老骨髓 Mφs 的吞噬功能也降低。通常被骨髓 Mφs 清除的衰老中性粒细胞在老年小鼠中明显增加,这与 Mφ 吞噬和吞噬作用的功能缺陷一致。在老年小鼠中,骨髄中的白细胞介素 1B(IL1B)升高,并且可以处理前体 IL1B 的半胱天冬酶 1 活性在骨髓 Mφs 和中性粒细胞中增加。从机制上讲,IL1B 信号对于诱导 HSC 中的血小板偏向是必需且充分的。在年轻小鼠中,吞噬细胞群的耗竭或吞噬作用受体 Axl 的缺失会扩大血小板偏向的 HSC。我们的数据支持这样一种模型,即衰老骨髓 Mφs 中炎症信号的增加和吞噬功能的降低导致衰老 HSCs 获得血小板偏向。这项工作强调了 Mφs 和 IL1B 在 HSC 与年龄相关的谱系倾斜中的指导作用,并揭示了它们作为抗老化靶标的操纵的治疗潜力。
Stem Cell Res Ther. 2024-9-29
Dev Cell. 2018-2-15
Nat Rev Cancer. 2025-8-14
Cells. 2025-7-10
Genes Dev. 2025-8-1
Immunometabolism (Cobham). 2025-5-9
Cancer Biol Med. 2025-5-6
Haematologica. 2025-7-1
Nat Rev Mol Cell Biol. 2019-5
J Clin Invest. 2017-11-1
Cell Stem Cell. 2017-5-4
J Exp Med. 2017-5-1
J Immunol. 2017-2-15